Skip to main navigation Skip to search Skip to main content

Targeting Alzheimer cell mitochondria via nilotinib as a therapeutic approach.

Research output: Contribution to conference › Abstract

Original languageAmerican English
StatePublished - 2018
EventAlzheimer's Drug Discovery Foundation (ADDF) - Washington, United States
Duration: Feb 4 2018 → Feb 6 2018

Conference

ConferenceAlzheimer's Drug Discovery Foundation (ADDF)
Country/TerritoryUnited States
CityWashington
Period2/4/18 → 2/6/18

Cite this